Clinical Trials Directory

Trials / Completed

CompletedNCT04325230

Prognostic Value of Arterial Spin Labeling Brain Perfusion MRI in Term Neonates With Hypoxic-ischemic Encephalopathy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
1 Day – 8 Days
Healthy volunteers
Not accepted

Summary

The main purpose of this study will be to evaluate the prognostic value at 3 months of life of brain perfusion MRI determined by Arterial Spin Labeling technique in the first week of life of term newborns with hypoxic-ischemic encephalopathy requiring management in neonatal intensive care unit.

Detailed description

Hypoxic-ischemic encephalopathy is the result of birth asphyxia due to transitory cerebral blood flow drop during perinatal period. It is the leading cause of neonatal encephalopathy, and thus a major cause of perinatal mortality, morbidity and adverse neurodevelopmental outcome. Usual care brain MRI is critically important in the diagnosis and prognosis. Lasting about 30 to 40 minutes, MRI exam includes successive sequences providing complementary information but none relatively to brain perfusion. Perfusion MRI without contrast media injection is possible using Arterial Spin Labeling (ASL) sequence. ASL is highly suitable for neonates, noninvasiveness, and lasts only 5 minutes. However, only one study assessed ASL as a prognostic factor. The purpose of the study is therefore to perform ASL sequence within usual care brain MRI.

Conditions

Interventions

TypeNameDescription
DEVICEArterial Spin Labeling sequenceASL sequence added to the usual care brain MRI

Timeline

Start date
2020-05-17
Primary completion
2023-01-12
Completion
2023-01-12
First posted
2020-03-27
Last updated
2023-04-28

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04325230. Inclusion in this directory is not an endorsement.